Retraction: MicroRNA-377 Suppresses Cell Proliferation and Invasion by Inhibiting TIAM1 Expression in Hepatocellular Carcinoma (PLoS ONE (2015) 10:3 (e0117714) DOI: 10.1371/journal.pone.0117714);MicroRNA-377 suppresses cell proliferation and invasion by inhibiting TIAM1 expression in hepatocellular carcinoma

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Chen, Guolin ^a   Lu, Lu ^a   Liu, Chang ^a   Shan, Lei ^a   Yuan, Di ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; MICRORNA; MICRORNA 377; T LYMPHOMA INVASION AND METASTASIS 1 PROTEIN; UNCLASSIFIED DRUG; GUANINE NUCLEOTIDE EXCHANGE FACTOR; MIRN377 MICRORNA, HUMAN; TIAM1 PROTEIN, HUMAN;

ARTICLE; CANCER INHIBITION; CARCINOMA CELL LINE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE TARGETING; HEPATOCELLULAR CARCINOMA CELL LINE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN RNA BINDING; PROTEIN TARGETING; RNA ANALYSIS; CELL MOTION; GENETICS; HEPG2 CELL LINE; LIVER TUMOR; METABOLISM;

CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MICRORNAS;

EID: 84928964033     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0266302     Document Type: Erratum

References (44)

1. Huang J (2009) Current progress in epigenetic research for hepatocarcinomagenesis. Sci China C Life Sci 52: 31-42. doi: 10.1007/s11427-009-0014-7 PMID: 19152082
2. Minguez B, Lachenmayer A (2011) Diagnostic and prognostic molecular markers in hepatocellular carcinoma. Dis Markers 31: 181-190. doi: 10.3233/DMA-2011-0841 PMID: 22045404
3. Karakatsanis A, Papaconstantinou I, Gazouli M, Lyberopoulou A, Polymeneas G, et al. (2013) Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol Carcinog 52: 297-303. doi: 10.1002/mc.21864 PMID: 22213236
4. Luk JM, Burchard J, Zhang C, Liu AM, Wong KF, et al. (2011) DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival. J Biol Chem 286: 30706-30713. doi: 10.1074/jbc.M111.229831 PMID: 21737452
5. Tsukamoto Y, Nakada C, Noguchi T, Tanigawa M, Nguyen LT, et al. (2010) MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res 70: 2339-2349. doi: 10.1158/0008-5472.CAN-09-2777 PMID: 20215506
6. Sun Q, Gu H, Zeng Y, Xia Y, Wang Y, et al. (2010) Hsa-mir-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression. Cancer Sci 101: 2241-2247. doi: 10.1111/j.1349-7006.2010.01667.x PMID: 20666778
7. Yuan Q, Loya K, Rani B, Mobus S, Balakrishnan A, et al. (2013) MicroRNA-221 overexpression accelerates hepatocyte proliferation during liver regeneration. Hepatology 57: 299-310. doi: 10.1002/hep.25984 PMID: 22821679
8. Niyazi M, Zehentmayr F, Niemoller OM, Eigenbrod S, Kretzschmar H, et al. (2011) MiRNA expression patterns predict survival in glioblastoma. Radiat Oncol 6: 153. doi: 10.1186/1748-717X-6-153 PMID: 22074483
9. Zhu LH, Liu T, Tang H, Tian RQ, Su C, et al. (2010) MicroRNA-23a promotes the growth of gastric adenocarcinoma cell line MGC803 and downregulates interleukin-6 receptor. FEBS J 277: 3726-3734. doi: 10.1111/j.1742-4658.2010.07773.x PMID: 20698883
10. Yang Q, Jie Z, Cao H, Greenlee AR, Yang C, et al. (2011) Low-level expression of let-7a in gastric cancer and its involvement in tumorigenesis by targeting RAB40C. Carcinogenesis 32: 713-722. doi: 10.1093/carcin/bgr035 PMID: 21349817
11. Suzuki H, Yamamoto E, Nojima M, Kai M, Yamano HO, et al. (2010) Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect. Carcinogenesis 31: 2066-2073. doi: 10.1093/carcin/bgq203 PMID: 20924086
12. Liang YJ, Wang QY, Zhou CX, Yin QQ, He M, et al. (2013) MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer. Carcinogenesis 34: 713-722. doi: 10.1093/carcin/bgs383 PMID: 23250910
13. Hatziapostolou M, Polytarchou C, Aggelidou E, Drakaki A, Poultsides GA, et al. (2011) An HNF4alphamiRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell 147: 1233-1247. doi: 10.1016/j.cell.2011.10.043 PMID: 22153071
14. Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH, et al. (2012) The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut 61: 278-289. doi: 10.1136/gut.2011.239145 PMID: 21672940
15. Li D, Zhao Y, Liu C, Chen X, Qi Y, et al. (2011) Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer. Clin Cancer Res 17: 1722-1730. doi: 10.1158/1078-0432.CCR-10-1800 PMID: 21350001
16. Jin Y, Peng D, Shen Y, Xu M, Liang Y, et al. (2013) MicroRNA-376c inhibits cell proliferation and invasion in osteosarcoma by targeting to transforming growth factor-alpha. DNA Cell Biol 32: 302-309. doi: 10.1089/dna.2013.1977 PMID: 23631646
17. Long XH, Mao JH, Peng AF, Zhou Y, Huang SH, et al. (2013) Tumor suppressive microRNA-424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthase. Exp Ther Med 5: 1048-1052. PMID: 23599729
18. Yoon SO, Chun SM, Han EH, Choi J, Jang SJ, et al. (2011) Deregulated expression of microRNA-221 with the potential for prognostic biomarkers in surgically resected hepatocellular carcinoma. Hum Pathol 42: 1391-1400. doi: 10.1016/j.humpath.2010.12.010 PMID: 21458843
19. Zhang S, Shan C, Kong G, Du Y, Ye L, et al. (2012) MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-kappaB-inducing kinase (NIK). Oncogene 31: 3607-3620. doi: 10.1038/onc.2011.523 PMID: 22105365
20. Jin Z, Selaru FM, Cheng Y, Kan T, Agarwal R, et al. (2011) MicroRNA-192 and-215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro. Oncogene 30: 1577-1585. doi: 10.1038/onc.2010.534 PMID: 21119604
21. Xu Y, Zhao F, Wang Z, Song Y, Luo Y, et al. (2012) MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1. Oncogene 31: 1398-1407. doi: 10.1038/onc.2011.340 PMID: 21822301
22. Chen H, Lin YW, Mao YQ, Wu J, Liu YF, et al. (2012) MicroRNA-449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins. Cancer Lett 320: 40-47. doi: 10.1016/j.canlet.2012.01.027 PMID: 22266187
23. Li X, Kong X, Wang Y, Yang Q (2013) BRCC2 inhibits breast cancer cell growth and metastasis in vitro and in vivo via downregulating AKT pathway. Cell Death Dis 4: e757. doi: 10.1038/cddis.2013.290 PMID: 23928696
24. Wang Q, Wang Y, Minto AW, Wang J, Shi Q, et al. (2008) MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J 22: 4126-4135. doi: 10.1096/fj.08-112326 PMID: 18716028
25. Beckman JD, Chen C, Nguyen J, Thayanithy V, Subramanian S, et al. (2011) Regulation of heme oxygenase-1 protein expression by miR-377 in combination with miR-217. J Biol Chem 286: 3194-3202. doi: 10.1074/jbc.M110.148726 PMID: 21106538
26. Zhang L, Volinia S, Bonome T, Calin GA, Greshock J, et al. (2008) Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci U S A 105: 7004-7009. doi: 10.1073/pnas.0801615105 PMID: 18458333
27. Lowery AJ, Miller N, Devaney A, McNeill RE, Davoren PA, et al. (2009) MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer. Breast Cancer Res 11: R27. doi: 10.1186/bcr2257 PMID: 19432961
28. Formosa A, Markert EK, Lena AM, Italiano D, Finazzi-Agro E, et al. (2013) MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells. Oncogene.
29. Arribas AJ, Gomez-Abad C, Sanchez-Beato M, Martinez N, Dilisio L, et al. (2013) Splenic marginal zone lymphoma: comprehensive analysis of gene expression and miRNA profiling. Mod Pathol 26: 889-901. doi: 10.1038/modpathol.2012.220 PMID: 23429603
30. Zhang R, Luo H, Wang S, Chen W, Chen Z, et al. (2014) MicroRNA-377 inhibited proliferation and invasion of human glioblastoma cells by directly targeting specificity protein 1. Neuro Oncol.
31. Habets GG, Scholtes EH, Zuydgeest D, van der Kammen RA, Stam JC, et al. (1994) Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell 77: 537-549. PMID: 7999144
32. Michiels F, Habets GG, Stam JC, van der Kammen RA, Collard JG (1995) A role for Rac in Tiam1-induced membrane ruffling and invasion. Nature 375: 338-340. PMID: 7753201
33. Minard ME, Kim LS, Price JE, Gallick GE (2004) The role of the guanine nucleotide exchange factor Tiam1 in cellular migration, invasion, adhesion and tumor progression. Breast Cancer Res Treat 84: 21-32. PMID: 14999151
34. Chen B, Ding Y, Liu F, Ruan J, Guan J, et al. (2012) Tiam1, overexpressed in most malignancies, is a novel tumor biomarker. Mol Med Rep 5: 48-53. doi: 10.3892/mmr.2011.612 PMID: 21971868
35. Yu LN, Zhang QL, Li X, Hua X, Cui YM, et al. (2013) Tiam1 transgenic mice display increased tumor invasive and metastatic potential of colorectal cancer after 1,2-dimethylhydrazine treatment. PLoS One 8: e73077. doi: 10.1371/journal.pone.0073077 PMID: 24069171
36. Liu L, Zhao L, Zhang Y, Zhang Q, Ding Y (2007) Proteomic analysis of Tiam1-mediated metastasis in colorectal cancer. Cell Biol Int 31: 805-814. PMID: 17376711
37. Adam L, Vadlamudi RK, McCrea P, Kumar R (2001) Tiam1 overexpression potentiates heregulin-induced lymphoid enhancer factor-1/beta-catenin nuclear signaling in breast cancer cells by modulating the intercellular stability. J Biol Chem 276: 28443-28450. PMID: 11328805
38. Engers R, Mueller M, Walter A, Collard JG, Willers R, et al. (2006) Prognostic relevance of Tiam1 protein expression in prostate carcinomas. Br J Cancer 95: 1081-1086. PMID: 17003780
39. Zhao L, Liu Y, Sun X, He M, Ding Y (2011) Overexpression of T lymphoma invasion and metastasis 1 predict renal cell carcinoma metastasis and overall patient survival. J Cancer Res Clin Oncol 137: 393-398. doi: 10.1007/s00432-010-0895-7 PMID: 20429013
40. Wang HM, Wang J (2012) Expression of Tiam1 in lung cancer and its clinical significance. Asian Pac J Cancer Prev 13: 613-615. PMID: 22524833
41. Liu S, Li Y, Qi W, Zhao Y, Huang A, et al. (2014) Expression of Tiam1 predicts lymph node metastasis and poor survival of lung adenocarcinoma patients. Diagn Pathol 9: 69. doi: 10.1186/1746-1596-9-69 PMID: 24661909
42. Huang J, Ye X, Guan J, Chen B, Li Q, et al. (2013) Tiam1 is associated with hepatocellular carcinoma metastasis. Int J Cancer 132: 90-100. doi: 10.1002/ijc.27627 PMID: 22573407
43. YangW, Lv S, Liu X, Liu H, Hu F (2010) Up-regulation of Tiam1 and Rac1 correlates with poor prognosis in hepatocellular carcinoma. Jpn J Clin Oncol 40: 1053-1059. doi: 10.1093/jjco/hyq086 PMID: 20522449
44. Ding Y, Chen B, Wang S, Zhao L, Chen J, et al. (2009) Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients. Int J Cancer 124: 653-658. doi: 10.1002/ijc.23954 PMID: 18972435